Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy

Abstract

Cardiac fibrosis and high levels of circulating collagen markers has been associated with left ventricular (LV) hypertrophy. However, the relationship to vascular hypertrophy and blood pressure (BP) load is unclear. In 204 patients with essential hypertension and electrocardiographic LV hypertrophy, we measured sitting BP, serum collagen type I carboxy-terminal telopeptide (ICTP) reflecting degradation, procollagen type I carboxy-terminal propeptide (PICP) reflecting synthesis and LV mass by echocardiography after 2 weeks of placebo treatment and after 1 year of antihypertensive treatment with a losartan- or an atenolol-based regimen. Furthermore, we measured intima–media thickness of the common carotid arteries (IMT), minimal forearm vascular resistance (MFVR) by plethysmography and ambulatory 24-h BP in around half of the patients. At baseline, PICP/ICTP was positively related to IMT (r=0.24, P<0.05), MFVRmen (r=0.35, P<0.01), 24-h systolic BP (r=0.24, P<0.05) and 24-h diastolic BP (r=0.22, P<0.05), but not to LV mass. After 1 year of treatment with reduction in systolic BP (175±15 vs 151±17 mmHg, P<0.001) and diastolic BP (99±8 vs 88±9 mmHg, P<0.001), ICTP was unchanged (3.7±1.4 vs 3.8±1.4 μg/l, NS) while PICP (121±39 vs 102±29 μg/l, P<0.001) decreased. The reduction in PICP/ICTP was related to the reduction in sitting diastolic BP (r=0.31, P<0.01) and regression of IMT (r=0.37, P<0.05) in patients receiving atenolol and to reduction in heart rate in patients receiving losartan (r=0.30, P<0.01). In conclusion, collagen markers reflecting net synthesis of type I collagen were positively related to vascular hypertrophy and BP load, suggesting that collagen synthesis in the vascular wall is increased in relation to high haemodynamic load in a reversible manner.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.

    Article  CAS  Google Scholar 

  2. Cuspidi C et al. Similarities and differences in structural and functional changes of left ventricle and carotid arteries in young borderline hypertensives and in athletes. J Hypertens 1996; 14: 759–764.

    Article  CAS  Google Scholar 

  3. Weber KT et al. Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory mechanisms. Eur Heart J 1995; 16(Suppl C): 24–28.

    Article  Google Scholar 

  4. Querejeta R et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101: 1729–1735.

    Article  CAS  Google Scholar 

  5. Bishop JE et al. Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats. Cardiovasc Res 2000; 47: 57–67.

    Article  CAS  Google Scholar 

  6. Wei S et al. Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction. J Card Fail 1999; 5: 117–126.

    Article  CAS  Google Scholar 

  7. Seccia TM et al. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. J Am Coll Cardiol 2003; 41: 666–673.

    Article  CAS  Google Scholar 

  8. Lopez B et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104: 286–291.

    Article  CAS  Google Scholar 

  9. Intengan HD, Schiffrin EL . Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36: 312–318.

    Article  CAS  Google Scholar 

  10. Franklin SS . Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance? Curr Hypertens Rep 2000; 2: 253–259.

    Article  CAS  Google Scholar 

  11. Koffi I et al. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. Eur J Pharmacol 1998; 361: 51–60.

    Article  CAS  Google Scholar 

  12. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: The LIFE study. Hypertension 1998; 32: 989–997.

    Article  CAS  Google Scholar 

  13. Diez J et al. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450–1456.

    Article  CAS  Google Scholar 

  14. Anderson KM, Odell PM, Wilson PW, Kannel WB . Cardiovascular disease risk profiles. Am Heart J 1991; 121 (1 Part 2): 293–298.

    Article  CAS  Google Scholar 

  15. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement [see comments]. J Am Coll Cardiol 1999; 34: 1625–1632.

    Article  CAS  Google Scholar 

  16. Dubin J, Wallerson DC, Cody RJ, Devereux RB . Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990; 120: 116–123.

    Article  CAS  Google Scholar 

  17. Nishimura RA, Abel MD, Hatle LK, Tajik AJ . Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc 1989; 64: 181–204.

    Article  CAS  Google Scholar 

  18. Imai Y et al. The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719–726.

    Article  CAS  Google Scholar 

  19. Conway J, Coats A . Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens 1989; 7(Suppl): S29–S32.

    CAS  Google Scholar 

  20. Howard G et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297–1304.

    Article  CAS  Google Scholar 

  21. Cooper KE, Edholm OG, Mottram RF . The blood flow in skin and muscle of the human forearm. J Physiol 1954; 128: 258–267.

    Article  Google Scholar 

  22. Utriainen T, Malmstrom R, Makimattila S, Yki JH . Methodological aspects, dose–response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555–564.

    Article  CAS  Google Scholar 

  23. Jensen LT et al. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 1990; 81: 52–57.

    Article  CAS  Google Scholar 

  24. Diez J et al. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis. Circulation 1996; 93: 1026–1032.

    Article  CAS  Google Scholar 

  25. Olsen MH et al. Sub-acute changes in circulating collagen markers during anti-hypertensive treatment. A LIFE substudy. J Am Coll Cardiol 2002; 39: 343B.

    Google Scholar 

  26. Rossi MA . Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998; 16: 1031–1041.

    Article  CAS  Google Scholar 

  27. Motz W, Scheler S, Schwartzkopff B, Strauer BE . Evaluation of cardiac damage in hypertension. J Cardiovasc Risk 1995; 2: 16–26.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the technical assistance by Ingrid Emanuel at Glostrup University, Denmark in measuring IMT. This work was supported by grants from The Danish Heart Foundation and Merck & Co., Inc., Copenhagen, Denmark as part of the LIFE-Echo substudy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M H Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsen, M., Christensen, M., Wachtell, K. et al. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy. J Hum Hypertens 19, 301–307 (2005). https://doi.org/10.1038/sj.jhh.1001819

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001819

Keywords

This article is cited by

Search

Quick links